TOBRADEX Side Effects

6771237-1 | Abnormal Sensation In Eye, Conjunctival Scar, Diplopia, Eye Discharge, Eye Irritation, Eye Pain, Eye Swelling, Foreign Body Sensation In Eyes, Headache
on May 28, 2010 Female patient from UNITED STATES , 45 years of age, weighting 200.0 lb, was diagnosed with antibiotic prophylaxis, eye operation, promotion of wound healing and was treated with Tobradex (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal sensation in eye, conjunctival scar, diplopia, eye discharge, eye irritation, eye pain, eye swelling, foreign body sensation in eyes, headache (What is headache?). Tobradex dosage: Qid Ophthalmic. During the same period patient was treated with ABILIFY (View Abilify Review and Abilify Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), CELEXA (View Celexa Review and Celexa Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

6768325-2 | Deafness
Patient was taking Tobradex (View Usage). Patient had the following side effects: deafness on Jun 01, 2010 from FRANCE Additional patient health information: Female patient , 88 years of age, was diagnosed with conjunctivitis and. Tobradex dosage: Ophthalmic. During the same period patient was treated with TEMERIT (NEBIVOLOL HYDROCHLORIDE) (View Temerit (nebivolol Hydrochloride) Review and Temerit (nebivolol Hydrochloride) Label ).

6755564-X | Deafness
Adverse event was reported on May 25, 2010 by a Female patient taking Tobradex (View Usage) (Dosage: Ophthalmic) was diagnosed with conjunctivitis and. Location: FRANCE , 88 years of age, After Tobradex was administered, patient had the following side effects: deafness.

6750610-1 | Hypoacusis
on May 11, 2010 Female patient from FRANCE , 88 years of age, was treated with Tobradex (View Usage). Patient experienced the following unwanted or unexpected effects: hypoacusis. Tobradex dosage: Ophthalmic.


6750608-3 | Blepharospasm, Ciliary Hyperaemia, Corneal Thinning, Eye Pain, Lacrimation Increased, Ocular Hyperaemia, Ulcerative Keratitis
on May 14, 2010 Female patient from SPAIN , 70 years of age, was diagnosed with postoperative care and was treated with Tobradex (View Usage). Patient had the following side effects: blepharospasm, ciliary hyperaemia, corneal thinning, eye pain, lacrimation increased, ocular hyperaemia, ulcerative keratitis. Tobradex dosage: 1 Gtt Qid , Ophthalmic. During the same period patient was treated with ACULAR (1 Gtt Qid, Ophthalmic) (View Acular Review and Acular Label ), TIMOFTOL (TIMOLOL MALEATE) 0.5 % OPHTHALMIC SOLUTION EYE DROPS, SOLUTI (1 Gtt Qid, Ophthalmic) (View Timoftol (timolol Maleate) 0.5 % Ophthalmic Solution Eye Drops, Soluti Review and Timoftol (timolol Maleate) 0.5 % Ophthalmic Solution Eye Drops, Soluti Label ).

6735325-8 | Abnormal Sensation In Eye, Burning Sensation, Diplopia, Eye Discharge, Eye Infection Bacterial, Eye Irritation, Eye Pain, Eye Swelling, Eyelid Disorder
Patient was taking Tobradex (View Usage). After Tobradex was administered, patient had the following side effects: abnormal sensation in eye, burning sensation, diplopia, eye discharge, eye infection bacterial, eye irritation, eye pain, eye swelling, eyelid disorder on May 05, 2010 from UNITED STATES Additional patient health information: Male patient , 45 years of age, weighting 200.0 lb, was diagnosed with eye operation, promotion of wound healing and. Tobradex dosage: Qid Ophthalmic. During the same period patient was treated with ABILIFY (View Abilify Review and Abilify Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), CELEXA (View Celexa Review and Celexa Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), VICODIN (View Vicodin Review and Vicodin Label ).

6619226-1 | Blepharoplasty, Blister, Contusion, Headache, Hypersensitivity, Impaired Driving Ability, Vision Blurred
Adverse event was reported on Nov 12, 2009 by a Female patient taking Tobradex (View Usage) (Dosage: Topical Qid Ophthalmic) was diagnosed with postoperative care and. Location: UNITED STATES , 61 years of age, Patient experienced the following unwanted or unexpected effects: blepharoplasty, blister, contusion, headache (What is headache?), hypersensitivity, impaired driving ability, vision blurred. During the same period patient was treated with ACIPHEX (View Aciphex Review and Aciphex Label ), RYNATAN (View Rynatan Review and Rynatan Label ), SINGULAIR (View Singulair Review and Singulair Label ), MICARDIS (View Micardis Review and Micardis Label ).

6615005-X | Brain Natriuretic Peptide Increased, Cardiac Failure, Decreased Appetite, Fluid Retention, Renal Failure, Respiratory Acidosis
on Feb 17, 2010 Female patient from FRANCE , 86 years of age, was treated with Tobradex (View Usage). Patient had the following side effects: brain natriuretic peptide increased, cardiac failure, decreased appetite, fluid retention, renal failure, respiratory acidosis. Tobradex dosage: Ophthalmic. During the same period patient was treated with SYMBICORT (View Symbicort Review and Symbicort Label ), BIPRETERAX (BI PREDONIUM) (View Bipreterax (bi Predonium) Review and Bipreterax (bi Predonium) Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), COUMADIN (View Coumadin Review and Coumadin Label ), NEXIUM (View Nexium Review and Nexium Label ), AERIUS (EBASTINE) (View Aerius (ebastine) Review and Aerius (ebastine) Label ). Patient was hospitalized.

6454569-6 | Aspiration, Cough, Decreased Activity, Dehydration, Dysphagia, Fluid Intake Reduced, Infection Susceptibility Increased, Pemphigoid, Red Blood Cell Count Increased
on Nov 02, 2009 Female patient from UNITED STATES , 93 years of age, was diagnosed with eye infection (What is eye infection?), superficial injury of eye and was treated with Tobradex (View Usage). After Tobradex was administered, patient had the following side effects: aspiration, cough, decreased activity, dehydration, dysphagia, fluid intake reduced, infection susceptibility increased, pemphigoid, red blood cell count increased. Tobradex dosage: (1/2 Inch Applied To Affected Eye Bid Ophthalmic). During the same period patient was treated with PREVACID (View Prevacid Review and Prevacid Label ). Patient was hospitalized.

6307914-6 | Aspiration, Cardiomegaly, Decreased Activity, Dehydration, Dementia, Disease Progression, Dysphagia, Goitre, Lung Neoplasm Malignant
Patient was taking Tobradex (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration, cardiomegaly, decreased activity, dehydration, dementia (What is dementia?), disease progression, dysphagia, goitre, lung neoplasm malignant on Jul 27, 2009 from UNITED STATES Additional patient health information: Female patient , 93 years of age, was diagnosed with corneal abrasion and. Tobradex dosage: (1/2 Inch Applied To Affected Eye Bid Ophthalmic). During the same period patient was treated with PREVACID (View Prevacid Review and Prevacid Label ). Patient was hospitalized.

6173036-0 | Cataract Operation Complication, Endophthalmitis, Uveitis, Vitritis
Adverse event was reported on Apr 20, 2009 by a Female patient taking Tobradex (View Usage) (Dosage: Ophthalmic) . Location: FRANCE , 87 years of age, Patient had the following side effects: cataract operation complication, endophthalmitis, uveitis, vitritis. During the same period patient was treated with ADRENALINE RENAUDIN (EPINEPHRINE) (View Adrenaline Renaudin (epinephrine) Review and Adrenaline Renaudin (epinephrine) Label ), CARBOCAINE (View Carbocaine Review and Carbocaine Label ), NEOSYNEPHRINE (PHENYLEPHRINE HYDROCHLORIDE) (View Neosynephrine (phenylephrine Hydrochloride) Review and Neosynephrine (phenylephrine Hydrochloride) Label ), PILOCARPINE HCL (PILOCARPINE HYDROCHLORIDE) (View Pilocarpine Hcl (pilocarpine Hydrochloride) Review and Pilocarpine Hcl (pilocarpine Hydrochloride) Label ), STERDEX(STER DEX) (View Sterdex(ster-dex) Review and Sterdex(ster-dex) Label ), TETRACAINE HYDROCHLORIDE (TETRACAINE HYDROCHLORIDE) (View Tetracaine Hydrochloride (tetracaine Hydrochloride) Review and Tetracaine Hydrochloride (tetracaine Hydrochloride) Label ), TROPICAMIDE (View Tropicamide Review and Tropicamide Label ), OCUFEN (View Ocufen Review and Ocufen Label ). Patient was hospitalized.

6172955-9 | Endophthalmitis, Hypopyon, Uveitis, Vitritis
on Apr 20, 2009 Female patient from FRANCE , 70 years of age, was treated with Tobradex (View Usage). After Tobradex was administered, patient had the following side effects: endophthalmitis, hypopyon, uveitis, vitritis. Tobradex dosage: Ophthalmic. During the same period patient was treated with ADRENALINE RENAUDIN (EPINEPHRINE) (View Adrenaline Renaudin (epinephrine) Review and Adrenaline Renaudin (epinephrine) Label ), CARBOCAINE (View Carbocaine Review and Carbocaine Label ), NEOSYNEPHRINE (PHENYLEPHRINE HYDROCHOLRIDE) (View Neosynephrine (phenylephrine Hydrocholride) Review and Neosynephrine (phenylephrine Hydrocholride) Label ), PILOCARPINE HCL (PILOCARPINE HYDROCHLORIDE) (View Pilocarpine Hcl (pilocarpine Hydrochloride) Review and Pilocarpine Hcl (pilocarpine Hydrochloride) Label ), STERDEX (STER DEX) (View Sterdex (ster-dex) Review and Sterdex (ster-dex) Label ), TETRACAINE HYDROCHLORIDE (TETRACAINE HYDROCHLORIDE) (View Tetracaine Hydrochloride (tetracaine Hydrochloride) Review and Tetracaine Hydrochloride (tetracaine Hydrochloride) Label ), TROPICAMIDE (View Tropicamide Review and Tropicamide Label ), OCUFEN (View Ocufen Review and Ocufen Label ). Patient was hospitalized.

6172946-8 | Endophthalmitis, Hypopyon, Uveitis, Vitritis
on Apr 20, 2009 Male patient from FRANCE , 78 years of age, was treated with Tobradex (View Usage). Patient experienced the following unwanted or unexpected effects: endophthalmitis, hypopyon, uveitis, vitritis. Tobradex dosage: Ophthalmic. During the same period patient was treated with NEOSYNEPHRINE (PHENYLEPHRINE HYDROCHLORIDE) (View Neosynephrine (phenylephrine Hydrochloride) Review and Neosynephrine (phenylephrine Hydrochloride) Label ), PILOCARPINE HCL (PILOCARPINE HYDROCHLORIDE) (View Pilocarpine Hcl (pilocarpine Hydrochloride) Review and Pilocarpine Hcl (pilocarpine Hydrochloride) Label ), STERDEX(STER DEX) (View Sterdex(ster-dex) Review and Sterdex(ster-dex) Label ), TROPICAMIDE (View Tropicamide Review and Tropicamide Label ). Patient was hospitalized.

6172944-4 | Endophthalmitis, Iris Adhesions, Keratitis, Uveitis, Vitritis
Patient was taking Tobradex (View Usage). Patient had the following side effects: endophthalmitis, iris adhesions, keratitis, uveitis, vitritis on Apr 20, 2009 from FRANCE Additional patient health information: Female patient , 62 years of age, . Tobradex dosage: Ophthalmic. During the same period patient was treated with ADRENALINE RENAUDIN (EPINEPHRINE) (View Adrenaline Renaudin (epinephrine) Review and Adrenaline Renaudin (epinephrine) Label ), STERDEX (STER DEX) (View Sterdex (ster-dex) Review and Sterdex (ster-dex) Label ), OCUFEN (View Ocufen Review and Ocufen Label ), TETRACAINE HYDROCHLORIDE (TETRACAINE HYDROCHLORIDE) (View Tetracaine Hydrochloride (tetracaine Hydrochloride) Review and Tetracaine Hydrochloride (tetracaine Hydrochloride) Label ), TROPICAMIDE (View Tropicamide Review and Tropicamide Label ). Patient was hospitalized.

6172934-1 | Endophthalmitis, Hypopyon, Uveitis, Vitritis
Adverse event was reported on Apr 20, 2009 by a Male patient taking Tobradex (View Usage) (Dosage: Ophthalmic) . Location: FRANCE , 86 years of age, After Tobradex was administered, patient had the following side effects: endophthalmitis, hypopyon, uveitis, vitritis. During the same period patient was treated with NEOSYNEPHRINE (PHENYLEPHRINE HYDROCHLORIDE) (View Neosynephrine (phenylephrine Hydrochloride) Review and Neosynephrine (phenylephrine Hydrochloride) Label ), PILOCARPINE HCL (PILOCARPINE HYDROCHLORIDE) (View Pilocarpine Hcl (pilocarpine Hydrochloride) Review and Pilocarpine Hcl (pilocarpine Hydrochloride) Label ), STERDEX (STER DEX) (View Sterdex (ster-dex) Review and Sterdex (ster-dex) Label ), TROPICAMIDE (View Tropicamide Review and Tropicamide Label ). Patient was hospitalized.

6164497-1 | Eye Pain, Inflammatory Pain, Oedema, Procedural Nausea, Procedural Pain, Procedural Vomiting
on Apr 07, 2009 Female patient from FRANCE , 56 years of age, was treated with Tobradex (View Usage). Patient experienced the following unwanted or unexpected effects: eye pain, inflammatory pain, oedema, procedural nausea, procedural pain, procedural vomiting. Tobradex dosage: 3 Gtts Opthalmic. During the same period patient was treated with OCUFEN (View Ocufen Review and Ocufen Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), VITAMIN A (View Vitamin A Review and Vitamin A Label ), PRIMPERAN ELIXIR (View Primperan Elixir Review and Primperan Elixir Label ). Patient was hospitalized.

6066067-2 | Endophthalmitis, Hypopyon, Uveitis, Vitritis
on Jan 19, 2009 Female patient from FRANCE , 70 years of age, was treated with Tobradex (View Usage). Patient had the following side effects: endophthalmitis, hypopyon, uveitis, vitritis. Tobradex dosage: Ophthalmic. During the same period patient was treated with ADRENALINE RENAUDIN (EPINEPHRINE) (View Adrenaline Renaudin (epinephrine) Review and Adrenaline Renaudin (epinephrine) Label ), CARBOCAINE (View Carbocaine Review and Carbocaine Label ), NEOSYNEPHRINE (PHENYLEPHRINE HYDROCHLORIDE) (View Neosynephrine (phenylephrine Hydrochloride) Review and Neosynephrine (phenylephrine Hydrochloride) Label ), PILOCARPINE (PILOCARPINE HYDROCHLORIDE) (View Pilocarpine (pilocarpine Hydrochloride) Review and Pilocarpine (pilocarpine Hydrochloride) Label ), STERDEX (STER DEX) (View Sterdex (ster-dex) Review and Sterdex (ster-dex) Label ), TETRACAINE (TETRACAINE) (View Tetracaine (tetracaine) Review and Tetracaine (tetracaine) Label ), TROPICAMIDE (View Tropicamide Review and Tropicamide Label ), OCUFEN (View Ocufen Review and Ocufen Label ). Patient was hospitalized.

6066062-3 | Cataract Operation Complication, Eye Infection Intraocular, Post Procedural Complication, Posterior Capsule Rupture, Uveitis, Vitritis
Patient was taking Tobradex (View Usage). After Tobradex was administered, patient had the following side effects: cataract operation complication, eye infection intraocular, post procedural complication, posterior capsule rupture, uveitis, vitritis on Jan 19, 2009 from FRANCE Additional patient health information: Female patient , 87 years of age, . Tobradex dosage: Ophthalmic. During the same period patient was treated with ADRENALINE RENAUDIN (EPINEPHRINE) (View Adrenaline Renaudin (epinephrine) Review and Adrenaline Renaudin (epinephrine) Label ), CARBOCAINE (View Carbocaine Review and Carbocaine Label ), NEOSYNEPHRINE (PHENYLEPHRINE HYDROCHLORIDE) (View Neosynephrine (phenylephrine Hydrochloride) Review and Neosynephrine (phenylephrine Hydrochloride) Label ), PILOCARPINE (PILOCARPINE HYDROCHLORIDE) (View Pilocarpine (pilocarpine Hydrochloride) Review and Pilocarpine (pilocarpine Hydrochloride) Label ), STERDEX (STER DEX) (View Sterdex (ster-dex) Review and Sterdex (ster-dex) Label ), TETRACAINE (TETRACAINE) (View Tetracaine (tetracaine) Review and Tetracaine (tetracaine) Label ), TROPICAMIDE (View Tropicamide Review and Tropicamide Label ), OCUFEN (View Ocufen Review and Ocufen Label ). Patient was hospitalized.

6066061-1 | Eye Infection Intraocular, Hypopyon, Post Procedural Complication, Uveitis, Visual Acuity Reduced, Vitritis
Adverse event was reported on Jan 19, 2009 by a Male patient taking Tobradex (View Usage) (Dosage: Ophtalmic) . Location: FRANCE , 86 years of age, Patient experienced the following unwanted or unexpected effects: eye infection intraocular, hypopyon, post procedural complication, uveitis, visual acuity reduced, vitritis. During the same period patient was treated with NEOSYNEPHRINE (PHENYLEPHRINE HYDROCHLORIDE) (View Neosynephrine (phenylephrine Hydrochloride) Review and Neosynephrine (phenylephrine Hydrochloride) Label ), PILOCARPINE (PILOCARPINE HYDROCHLROIDE) (View Pilocarpine (pilocarpine Hydrochlroide) Review and Pilocarpine (pilocarpine Hydrochlroide) Label ), STERDEX (STER DEX) (View Sterdex (ster-dex) Review and Sterdex (ster-dex) Label ), TROPICAMIDE (View Tropicamide Review and Tropicamide Label ). Patient was hospitalized.

6066000-3 | Eye Infection Intraocular, Eye Inflammation, Hypopyon, Uveitis, Visual Acuity Reduced, Vitritis
on Jan 19, 2009 Male patient from FRANCE , 78 years of age, was treated with Tobradex (View Usage). Patient had the following side effects: eye infection intraocular, eye inflammation, hypopyon, uveitis, visual acuity reduced, vitritis. Tobradex dosage: Ni, Ophthalmic. During the same period patient was treated with NEOSYNEPHRINE (PHENYLEPHRINE HYDROCHLORIDE) (View Neosynephrine (phenylephrine Hydrochloride) Review and Neosynephrine (phenylephrine Hydrochloride) Label ), PILOCARPINE (PILOCARPHINE HYDROCHLORIDE) (View Pilocarpine (pilocarphine Hydrochloride) Review and Pilocarpine (pilocarphine Hydrochloride) Label ), STERDEX (STER DEX) (View Sterdex (ster-dex) Review and Sterdex (ster-dex) Label ), TROPICAMIDE (View Tropicamide Review and Tropicamide Label ). Patient was hospitalized.

6065999-9 | Eye Infection Intraocular, Hypopyon, Iris Adhesions, Uveitis, Visual Acuity Reduced, Vitritis
on Jan 19, 2009 Female patient from FRANCE , 62 years of age, was treated with Tobradex (View Usage). After Tobradex was administered, patient had the following side effects: eye infection intraocular, hypopyon, iris adhesions, uveitis, visual acuity reduced, vitritis. Tobradex dosage: Ni, Ophthalmic. During the same period patient was treated with ADRENALINE RENAUDIN (EPINEPHRINE) (View Adrenaline Renaudin (epinephrine) Review and Adrenaline Renaudin (epinephrine) Label ), STERDEX (STER DEX) (View Sterdex (ster-dex) Review and Sterdex (ster-dex) Label ), OCUFEN (View Ocufen Review and Ocufen Label ), TETRACAINE (TETRACAINE) (View Tetracaine (tetracaine) Review and Tetracaine (tetracaine) Label ), TROPICAMIDE (View Tropicamide Review and Tropicamide Label ). Patient was hospitalized.

6065984-7 | Eye Infection Intraocular, Uveitis, Vitritis
Patient was taking Tobradex (View Usage). Patient experienced the following unwanted or unexpected effects: eye infection intraocular, uveitis, vitritis on Jan 16, 2009 from FRANCE Additional patient health information: Male patient , 57 years of age, . Tobradex dosage: Ni, Ophthalmic. During the same period patient was treated with NEOSYNEPHRINE (PHENYLEPHRINE HYDROCHLORIDE) (View Neosynephrine (phenylephrine Hydrochloride) Review and Neosynephrine (phenylephrine Hydrochloride) Label ), PILOCARPINE (View Pilocarpine Review and Pilocarpine Label ), STERDEX (STER DEX) (View Sterdex (ster-dex) Review and Sterdex (ster-dex) Label ), TROPICAMIDE (View Tropicamide Review and Tropicamide Label ). Patient was hospitalized.

6051758-X | Keratitis
Adverse event was reported on Jan 21, 2009 by a Female patient taking Tobradex (View Usage) (Dosage: Apply To Lid Margins 2x Daily Ophthalmic) was diagnosed with blepharitis and. Location: UNITED STATES , child 7 years of age, weighting 52.00 lb, Patient had the following side effects: keratitis.

6032103-2 | Corneal Disorder, Corneal Perforation
on Dec 23, 2008 Female patient from CHINA , 52 years of age, was treated with Tobradex (View Usage). After Tobradex was administered, patient had the following side effects: corneal disorder, corneal perforation. Tobradex dosage: Tid Ophthalmic. During the same period patient was treated with DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), LOMEFLOXACIN (LOMEFLOXACIN) (View Lomefloxacin (lomefloxacin) Review and Lomefloxacin (lomefloxacin) Label ), DEXAMETHASONE SODIUM PHOSPHATE (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ).

6009955-5 | Dermatitis Contact, Ear Infection, Eosinophilia, Pruritus, Rash Maculo-papular, Toxic Skin Eruption
on Dec 05, 2008 Female patient from FRANCE , 74 years of age, was treated with Tobradex (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis contact, ear infection (What is ear infection?), eosinophilia, pruritus, rash maculo-papular, toxic skin eruption. Tobradex dosage: Df Bid, Ophthalmic. During the same period patient was treated with PYOSTACINE (PRISTINAMYCIN) (View Pyostacine (pristinamycin) Review and Pyostacine (pristinamycin) Label ), OFLOCET (OFLOXACIN) (View Oflocet (ofloxacin) Review and Oflocet (ofloxacin) Label ), TRIVASTAL (PIRIBEDIL) (View Trivastal (piribedil) Review and Trivastal (piribedil) Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), SINGULAIR (View Singulair Review and Singulair Label ), XANAX (View Xanax Review and Xanax Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

5794523-0 | Cataract, Disease Progression, Herpes Zoster Ophthalmic, Retinal Detachment, Uveitis, Vitritis
Patient was taking Tobradex (View Usage). Patient had the following side effects: cataract (What is cataract?), disease progression, herpes zoster ophthalmic, retinal detachment, uveitis, vitritis on Jun 12, 2008 from FRANCE Additional patient health information: Male patient , 62 years of age, was diagnosed with uveitis and. Tobradex dosage: 1 Gtt Qid Ophthalmic. During the same period patient was treated with AZOPT (1 Gtt Bid Ophthalmic) (View Azopt Review and Azopt Label ), EXOCINE (OFLOXACIN) (View Exocine (ofloxacin) Review and Exocine (ofloxacin) Label ). Patient was hospitalized.

5736152-0 | Chemical Burns Of Eye, Eye Irritation, Headache, Instillation Site Irritation, Pain, Vomiting
Adverse event was reported on May 09, 2008 by a Male patient taking Tobradex (View Usage) (Dosage: 1 Drop Into Eye) . Location: UNITED STATES , 19 years of age, After Tobradex was administered, patient had the following side effects: chemical burns of eye, eye irritation, headache (What is headache?), instillation site irritation, pain (What is pain?), vomiting.

5727219-1 | Cataract, Eye Disorder, Herpes Zoster Ophthalmic, Retinal Detachment, Vitritis
on Apr 16, 2008 Male patient from FRANCE , 62 years of age, was diagnosed with uveitis and was treated with Tobradex (View Usage). Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?), eye disorder, herpes zoster ophthalmic, retinal detachment, vitritis. Tobradex dosage: 4 Gtts/day Ophthalmic. During the same period patient was treated with AZOPT (Ophthalmic) (View Azopt Review and Azopt Label ). Patient was hospitalized.

5720595-5 | Cataract, Post Procedural Complication
on Apr 25, 2008 Female patient from UNITED STATES , 49 years of age, weighting 188.0 lb, was diagnosed with eye laser surgery and was treated with Tobradex (View Usage). Patient had the following side effects: cataract (What is cataract?), post procedural complication. Tobradex dosage: 1 Drop 4x Per Day Ophthalmic.

5706098-2 | Eye Disorder, Eye Irritation, Eye Pain, Lacrimation Decreased, Ocular Hyperaemia
Patient was taking Tobradex (View Usage). After Tobradex was administered, patient had the following side effects: eye disorder, eye irritation, eye pain, lacrimation decreased, ocular hyperaemia on Mar 28, 2008 from DENMARK Additional patient health information: Female patient , 36 years of age, was diagnosed with keratitis and. Tobradex dosage: 1 Gtt Ou Qid. During the same period patient was treated with ULTRACORTENOL (PREDNISOLONE ACETATE) (View Ultracortenol (prednisolone Acetate) Review and Ultracortenol (prednisolone Acetate) Label ). Patient was hospitalized.

5676674-4 | Eye Irritation, Eye Pain, Lacrimation Decreased, Ocular Hyperaemia
Adverse event was reported on Mar 06, 2008 by a Female patient taking Tobradex (View Usage) (Dosage: 1 Gtt Pi Qid;opthalmic) was diagnosed with keratitis and. Location: DENMARK , 36 years of age, Patient experienced the following unwanted or unexpected effects: eye irritation, eye pain, lacrimation decreased, ocular hyperaemia. During the same period patient was treated with ULTRACORTENOL (PREDNISOLONE ACETATE) (View Ultracortenol (prednisolone Acetate) Review and Ultracortenol (prednisolone Acetate) Label ). Patient was hospitalized.

5614844-1 | Hepatic Encephalopathy
on Jan 16, 2008 Female patient from FRANCE , 70 years of age, was diagnosed with cataract operation and was treated with Tobradex (View Usage). Patient had the following side effects: hepatic encephalopathy. Tobradex dosage: 1 Gtt Tid In Od Ophthalmic. During the same period patient was treated with VITAMIN K (VITAMIN K NOS) (View Vitamin K (vitamin K Nos) Review and Vitamin K (vitamin K Nos) Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), INEXIUM (ESOMPERAZOLE SODIUM) (View Inexium (esomperazole Sodium) Review and Inexium (esomperazole Sodium) Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), AMARYL (View Amaryl Review and Amaryl Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

5572324-6 | Encephalopathy
on Dec 05, 2007 Female patient from FRANCE , 70 years of age, was diagnosed with cataract operation and was treated with Tobradex (View Usage). After Tobradex was administered, patient had the following side effects: encephalopathy. Tobradex dosage: 1 Gtt Tid In Od, Ophthalmic. During the same period patient was treated with VITAMIN K (VITAMIN K NOS) (View Vitamin K (vitamin K Nos) Review and Vitamin K (vitamin K Nos) Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), NEXIUM (View Nexium Review and Nexium Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), AMARYL (View Amaryl Review and Amaryl Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

5444363-7 | Diplopia, Impaired Driving Ability, Vision Blurred
Patient was taking Tobradex (View Usage). Patient experienced the following unwanted or unexpected effects: diplopia, impaired driving ability, vision blurred on Sep 04, 2007 from UNITED STATES Additional patient health information: Female patient , 59 years of age, weighting 215.0 lb, was diagnosed with eye infection (What is eye infection?) and. Tobradex dosage: 2 Drops Ophtalmic.

5402656-3 | Epistaxis, Eye Infection, Keratoconjunctivitis Sicca, Unevaluable Event, Vitreous Floaters
Adverse event was reported on Jul 30, 2007 by a Female patient taking Tobradex (View Usage) (Dosage: 1 Drop 3 Times Per Day Intraocular) was diagnosed with conjunctivitis and. Location: UNITED STATES , 36 years of age, weighting 140.0 lb, Patient had the following side effects: epistaxis, eye infection (What is eye infection?), keratoconjunctivitis sicca, unevaluable event, vitreous floaters.

5332156-0 | Eosinophilia, Granulocytes Maturation Arrest, Granulocytopenia, Thrombocytopenia
on May 04, 2007 Female patient from FRANCE , 71 years of age, was treated with Tobradex (View Usage). After Tobradex was administered, patient had the following side effects: eosinophilia, granulocytes maturation arrest, granulocytopenia, thrombocytopenia. Tobradex dosage: Eye Drops*. During the same period patient was treated with LEXOMIL (BROMAZEPAM) (View Lexomil (bromazepam) Review and Lexomil (bromazepam) Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), ENBREL (View Enbrel Review and Enbrel Label ), COSOPT (View Cosopt Review and Cosopt Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ATARAX (View Atarax Review and Atarax Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), FOSAMAX (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

5293588-2 | Granulocytopenia, Thrombocytopenia
on Mar 22, 2007 Female patient from FRANCE , 71 years of age, was treated with Tobradex (View Usage). Patient experienced the following unwanted or unexpected effects: granulocytopenia, thrombocytopenia. Tobradex dosage: Eye Drops; Ni; Ophthalmic. During the same period patient was treated with LEXOMIL (BROMAZEPAM (View Lexomil (bromazepam Review and Lexomil (bromazepam Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), ENBREL (View Enbrel Review and Enbrel Label ), COSOPT (COSOPT) (View Cosopt (cosopt) Review and Cosopt (cosopt) Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ATARAX (View Atarax Review and Atarax Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FOSAMAX (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

5214717-2 | Conjunctival Haemorrhage, Periorbital Haematoma, Periorbital Oedema
Patient was taking Tobradex (View Usage). Patient had the following side effects: conjunctival haemorrhage, periorbital haematoma, periorbital oedema on Dec 13, 2006 from ITALY Additional patient health information: Female patient , 42 years of age, was diagnosed with conjunctivitis and. Tobradex dosage: Eye Drops, Suspension Ophthalmic. During the same period patient was treated with OFTAQUIX (LEVOFLOXACIN) (View Oftaquix (levofloxacin) Review and Oftaquix (levofloxacin) Label ).

5196199-2 | Conjunctival Haemorrhage, Eyelid Oedema, Periorbital Haematoma
Adverse event was reported on Dec 11, 2006 by a Male patient taking Tobradex (View Usage) (Dosage: Eye Drops Ophthalmic) was diagnosed with conjunctivitis and. Location: ITALY , 48 years of age, After Tobradex was administered, patient had the following side effects: conjunctival haemorrhage, eyelid oedema, periorbital haematoma. During the same period patient was treated with DICLOTEARS(DICLOFENAC SODIUM) (View Diclotears(diclofenac Sodium) Review and Diclotears(diclofenac Sodium) Label ).

5135237-X | Dry Mouth, Dysgeusia
on Oct 24, 2006 Male patient from UNITED STATES , 58 years of age, weighting 170.0 lb, was treated with Tobradex (View Usage). Patient experienced the following unwanted or unexpected effects: dry mouth, dysgeusia. Tobradex dosage: 1 Drop Into Each Eye Four Times Daily Ophthalmic.

5031786-3 | Condition Aggravated, Renal Failure
on Jun 01, 2006 Female patient from FRANCE , 89 years of age, was treated with Tobradex (View Usage). Patient had the following side effects: condition aggravated, renal failure. Tobradex dosage: . During the same period patient was treated with TROPICAMIDE (View Tropicamide Review and Tropicamide Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), EPOETIN BETA (View Epoetin Beta Review and Epoetin Beta Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

5027584-7 | Herpes Zoster
Patient was taking Tobradex (View Usage). After Tobradex was administered, patient had the following side effects: herpes zoster on Jun 14, 2006 from UNITED STATES Additional patient health information: Female patient , 58 years of age, weighting 138.0 lb, was diagnosed with ear infection (What is ear infection?) and. Tobradex dosage: 3 Drops 3 Times A Day Otic.

4851116-7 | Deafness Unilateral, Ear Discomfort
Adverse event was reported on Nov 22, 2005 by a Male patient taking Tobradex (View Usage) (Dosage: 3 Gtts Tid Ea) was diagnosed with ear infection (What is ear infection?) and. Location: UNITED STATES , 32 years of age, weighting 205.0 lb, Patient experienced the following unwanted or unexpected effects: deafness unilateral, ear discomfort. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

4778685-X | Cataract, Impaired Work Ability, Photopsia, Vitreous Floaters
on Sep 07, 2005 Female patient from NETHERLANDS , 52 years of age, was diagnosed with keratitis and was treated with Tobradex (View Usage). Patient had the following side effects: cataract (What is cataract?), impaired work ability, photopsia, vitreous floaters. Tobradex dosage: 6 Gtts Qd Opht. During the same period patient was treated with TRIAMTERENUM (View Triamterenum Review and Triamterenum Label ).